EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Early experience of using regional citrate anticoagulation for continuous renal replacement therapy in critically ill patients in a resource‐limited setting

M Shahnaz Hasan iD, Muhammad Afif Jamaludin, Sarah Aliah Mohd Azman, Rafidah Atan, Mei Hoon Yap, Zheng-Yii Lee, Nor'azim Mohd Yunos

Nephrology · 2024

DOI: 10.1111/nep.14330 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Nephrology, 2024. Verfasst von M Shahnaz Hasan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Continuous Renal Replacement Therapy, Critical Illness, Anticoagulants, Citric Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Malaysian Society of Intensive Care (MSIC) Research Seed Grant 2021.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Despite the superiority of regional citrate anticoagulation (RCA) in continuous renal replacement therapy (CRRT), its application is limited in resource‐limited settings. We aim to explore the cost and safety of RCA for CRRT in critically ill patients, compared to usual care.

Methods

This prospective observational study included patients requiring CRRT in a tertiary intensive care unit (ICU) from February 2022 to January 2023. They were classified to either the RCA or usual care groups based on the anticoagulation technique chosen by the treating physician, considering contraindications. The CRRT prescription follows the institutional protocol. All relevant data were obtained from the ICU CRRT‐RCA charts and electronic medical records. A cost analysis was performed.

Results

A total of 54 patients (27 per group) were included, with no demographic differences. Sequential Organ Failure Assessment score and lactate levels were significantly higher in the usual care group. The number of filters used were comparable ( p = .108). The median filter duration in the RCA group was numerically longer (35.00 [15.50–56.00] vs. 23.00 [17.00–29.00] h), but not statistically significant ( p = .253). The duration of mechanical ventilation, vasopressor requirement, and mortality were similar, but the RCA group had a significantly longer ICU stay. The rate of adverse events was similar, with four severe metabolic alkalosis cases in the RCA group. The RCA group had higher total cost per patient per day (USD 611 vs. 408; p = .013).

Conclusion

In this resource‐limited setting, RCA for CRRT appeared safe and had clinically longer filter lifespan compared with usual care, albeit the increased cost.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Continuous Renal Replacement TherapyCritical IllnessAnticoagulantsCitric AcidHumansMaleFemaleProspective StudiesMiddle AgedAgedIntensive Care UnitsAcute Kidney InjuryHealth ResourcesResource-Limited Settings

Stichwörter der Autor:innen

acute kidney injuryanticoagulantscitratescontinuous renal replacement therapycritical care

Substanzen

AnticoagulantsCitric Acid

Autor:innen und Institutionen

  • Department of Anaesthesiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
  • Department of Anaesthesiology, Universiti Malaya Medical Centre, Kuala Lumpur, Malaysia.
  • Department of Cardiac Anesthesiology and Intensive Care Medicine, Charité Berlin, Berlin, Germany.

ORCID-Profile: M Shahnaz Hasan

Förderung

  • Malaysian Society of Intensive Care (MSIC) Research Seed Grant 2021

Zitieren

APA

Hasan, M. S., Jamaludin, M. A., Mohd Azman, S. A., Atan, R., Yap, M. H., Lee, Z. Y., & Mohd Yunos, N. (2024). Early experience of using regional citrate anticoagulation for continuous renal replacement therapy in critically ill patients in a resource‐limited setting. Nephrology. https://doi.org/10.1111/nep.14330

Vancouver

Hasan MS, Jamaludin MA, Mohd Azman SA, Atan R, Yap MH, Lee ZY, et al. Early experience of using regional citrate anticoagulation for continuous renal replacement therapy in critically ill patients in a resource‐limited setting. Nephrology. 2024. doi:10.1111/nep.14330

BibTeX
@article{Hasan2024,
  author = {Hasan, M Shahnaz and Jamaludin, Muhammad Afif and Mohd Azman, Sarah Aliah and Atan, Rafidah and Yap, Mei Hoon and Lee, Zheng-Yii and Mohd Yunos, Nor'azim},
  title = {Early experience of using regional citrate anticoagulation for continuous renal replacement therapy in critically ill patients in a resource‐limited setting},
  journal = {Nephrology},
  year = {2024},
  doi = {10.1111/nep.14330}
}
Kostenlos starten →